Funding for this research was provided by:
National Heart Foundation of Australia (101204, 100848)
National Health and Medical Research Council (1105271)
NSW Ministry of Health (H18/31086)
Received: 11 November 2019
Accepted: 25 November 2019
First Online: 24 December 2019
Ethics approval and consent to participate
: All patients provided signed informed consent for research use of their material; the study was approved by the AUTH Bioethics Committee (Approval #79/10.6.2014) and by the Papageorgiou Hospital Institutional Review Board (193rd Meeting decision, 15.1.2014).
: Written informed consent was obtained from the patients for publication.
: George Fountzilas reports personal fees from Pfizer, personal fees from Sanofi, personal fees from Roche, personal fees from Astra-Zeneca, outside the submitted work. Qing Wang, Vassiliki Kotoula, Pei-Chen Hsu, Kyriaki Papadopoulou, Joshua W.K. Ho and Eleni Giannoulatou declare that they have no competing interests.